Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127437962 | 12743796 | 2 | F | 20160913 | 20160914 | 20160921 | EXP | PHHY2016PL123665 | SANDOZ | WOJCINSKA AA. INTERACTIONS AND ADVERSE EFFECTS OF MOOD STABILIZERS ? PART 3. PSYCHIATRIA PO DYPLOMIE. 2016 | 44.00 | YR | M | Y | 0.00000 | 20160921 | OT | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127437962 | 12743796 | 1 | PS | VALPROATE SODIUM. | VALPROATE SODIUM | 1 | Unknown | 100 MG, QD | 78290 | 100 | MG | QD | |||||||
| 127437962 | 12743796 | 2 | C | CLOZAPINE. | CLOZAPINE | 1 | Unknown | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 127437962 | 12743796 | 3 | C | CLOZAPINE. | CLOZAPINE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127437962 | 12743796 | 1 | Bipolar disorder |
| 127437962 | 12743796 | 2 | Bipolar disorder |
| 127437962 | 12743796 | 3 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127437962 | 12743796 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127437962 | 12743796 | Alopecia | |
| 127437962 | 12743796 | Gingival bleeding | |
| 127437962 | 12743796 | Thrombocytopenia | |
| 127437962 | 12743796 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |